etoposide phosphate has been researched along with Lymphoma, Non-Hodgkin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Boyé, P; Floch, F; Fournel-Fleury, C; Serres, F; Tierny, D | 1 |
Briggs, A; Chow, HH; Dorr, RT; Kintzel, P; List, A; Meyers, R | 1 |
Alscher, A; Casper, J; Decker, S; Freund, M; Junghanss, C; Kleine, HD; Knopp, A; Köhne, CH; Leithäuser, M; Wilhelm, S | 1 |
2 trial(s) available for etoposide phosphate and Lymphoma, Non-Hodgkin
Article | Year |
---|---|
Prognostic value of pretreatment plasma D-dimer level in dogs with intermediate to high-grade non-Hodgkin lymphoma.
Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Double-Blind Method; Etoposide; Female; Fibrin Fibrinogen Degradation Products; Lymphoma, Non-Hodgkin; Male; Organophosphorus Compounds; Podophyllotoxin; Prognosis; Thymidine Kinase | 2021 |
Comparative pharmacokinetic study of high-dose etoposide and etoposide phosphate in patients with lymphoid malignancy receiving autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Chromatography, High Pressure Liquid; Etoposide; Hodgkin Disease; Humans; Life Expectancy; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Middle Aged; Multiple Myeloma; Organophosphorus Compounds; Stem Cell Transplantation; Time Factors; Transplantation, Autologous | 2003 |
1 other study(ies) available for etoposide phosphate and Lymphoma, Non-Hodgkin
Article | Year |
---|---|
High-dose etoposide phosphate and G-CSF mobilizes peripheral blood stem cells in patients that previously failed to mobilize.
Topics: Adult; Choriocarcinoma; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Germinoma; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Middle Aged; Organophosphorus Compounds; Therapeutic Equivalency; Transplantation Conditioning; Whole-Body Irradiation | 2001 |